Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Global Macro Monitor
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Global Risk Monitor: Week In Review – April 17

% of readers think this story is Fact. Add your two cents.


Markets are currently behaving with the volatile, erratic energy of a teenager on a sugar high, oscillating between “the war is over” euphoria and the sobering realization that geopolitical stability is currently being drafted on a napkin in a war room. The headline-driven rally has been a masterclass in price discovery through chaos. Markets priced out aggressive rate hikes and sprinted toward record highs on the premature assumption that a ceasefire between Israel and Lebanon, coupled with a pledge to open the Strait of Hormuz, meant the geopolitical risk premium was dead.

Of course, the reality of the weekend was far less cooperative. Iran’s Revolutionary Guards promptly declared the Strait closed again, citing the continued U.S. blockade on Iranian ports, a maneuver the Guards termed “strict control”. President Trump, playing his part in this theater with characteristic flair, dismissed the Iranian maneuvers as “getting a little cute” while simultaneously maintaining the very blockade that necessitates the closure. It is a delightfully circular logic: the U.S. blockades ports to choke off funding, Iran retaliates by choking off shipping, and the market spends the weekend sweating the resulting oil price volatility.

Forecasting in this climate is essentially a parlor game for the desperate. When price action is dictated by whether a foreign minister or a President decides to tweet or hold a press conference, “fundamental analysis” feels like an exercise in nostalgia. The suspicious efficiency with which some desks seem to position ahead of these policy flip-flops suggests that the “insider trading” playbook is not just alive and well,but thriving in the current volatility. We are seeing a market that wants to believe the oil price shock is “short-lived,” yet the technicals, specifically the extreme RSI overbought readings across major indices, suggest that we may have outrun our own shadow. Caution is not just warranted; it’s likely the only thing preventing a catastrophic exit when the next headline inevitably spoils the party.

Regional Performance Bullet Points

  • United States: Indices notched record highs, with the S&P 500 now up 4.1% YTD and the Nasdaq rallying 5.28%. Despite the enthusiasm, market breadth remains narrow, heavily driven by mega-cap tech.
  • Europe: The STOXX 600 climbed 1.91%. The IMF, however, provided a sobering reality check by trimming eurozone growth forecasts, warning that the Middle East conflict could trigger a “major energy crisis”.
  • Japan: Markets showed resilience with the Nikkei 225 gaining 2.73% to hit an all-time high. However, the Bank of Japan appears paralyzed, with Governor Ueda refraining from clear rate-hike signals due to the high-uncertainty energy environment.
  • China: A stronger-than-expected 5.0% Q1 GDP print provided a floor for equity rebounds. Nevertheless, the recovery remains deeply uneven; while exports and industrial output showed life, retail sales slowed to a crawl, and property investment plummeted by 11.2%.
  • Hungary: A political transition marked by Viktor Orbán’s electoral defeat, spurred a flurry of optimism. Investors are betting that a change in economic management could unlock over EUR 30 billion in frozen EU funds, driving gains across equities and bonds.

The Week Ahead

The consensus for the coming week is leaning toward a “profit-taking” pullback. We are technically overbought, and the market’s propensity to assume a best-case scenario regarding the Strait of Hormuz feels like an accident waiting to happen.

  • Earnings Volatility: The “kickoff” of the Q1 earnings season continues. Keep a close watch on high-beta names like Tesla, ServiceNow, and Lam Research. If these recent winners stumble, expect the current rally to find a very sharp ceiling.
  • Macro Catalysts: We expect a “mean reversion” narrative to take hold. Tuesday’s Retail Sales data will be crucial; keep in mind that nominal gains may be masking the impact of higher energy prices on volume.
  • The Warsh Factor: The confirmation hearing for Kevin Warsh as the potential next Fed Chair is on the calendar for Tuesday. Expect him to be aggressively vague to avoid riling the Senate or the current FOMC, but any slips in his “neutral rate” rhetoric will be pounced upon by desks looking for a reason to sell the news.

Bottom line: The current risk-on stance is fragile. With the Strait of Hormuz situation still unresolved and technical indicators flashing warning signs, we are leaning into a “Slight to Moderately Bearish” posture for the week.


Source: https://global-macro-monitor.com/2026/04/18/global-risk-monitor-week-in-review-april-17/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login